ReviewBioMed research international2023
Recent Advances in Pyridine Scaffold: Focus on Chemistry, Synthesis, and Antibacterial Activities.
Review in BioMed research international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Synthesis and evaluation of the antimicrobial activity of novel esters, β-diketones, chromones and pyrazoles.RSC advances · 2026Article
- Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000-2025).Medicinal research reviews · 2026Review
- Synthesis, Characterization, and Biological Assessment of 2-Methoxynicotinonitrile Derivatives.Chemistry & biodiversity · 2026Article
- Coordination-Driven Direct C─H Metalation of N-Heterocycles With a Superbasic Co(II) Amide Co(TMP)Angewandte Chemie (International ed. in English) · 2026Article
- Synthesis and Fungicidal Evaluation of Pyridylpyrazole Derivatives Bearing a Benzoxazinone Scaffold via a Metal-Free Approach.International journal of molecular sciences · 2026Article
- The Pyridylketenyl Anion: Entry to Diverse N-Heterocycles.Journal of the American Chemical Society · 2026Article
- Synthesis and quantum chemical studies of polyfunctionally substituted pyridines incorporating pyrimidine moiety for corrosion Inhibition.Scientific reports · 2026Article
- Photocatalytic construction ofChemical science · 2026Article
- Exploring Pyridine-Based Schemes: A Comprehensive Review on their Synthesis and Therapeutic Applications.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2026Review
- Sustainable synthesis of Schiff base derivativesRSC advances · 2025Article
- Antiparasitic and Antifungal Activities of Cetyl-Maritima, a NewAntibiotics (Basel, Switzerland) · 2025Article
- Reaction strategies for the meta-selective functionalization of pyridine through dearomatization.Molecular diversity · 2025Review
- Discovery of Quinazolone Pyridiniums as Potential Broad-Spectrum Antibacterial Agents.Molecules (Basel, Switzerland) · 2025Article
- Cracking the code: the clinical and molecular impact of aminopyridines; a review (2019-2024).RSC advances · 2025Review
- Pyridine Derivatives: A Comprehensive Review of Their Potential as Anti-Diabetic Agents.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025Review
- Comprehensive drug-like assessment of pyridine carbothioamide analogs: from molecular modeling toFuture medicinal chemistry · 2025Article
- Novel Copper(II) Coordination Compounds Containing Pyridine Derivatives ofMolecules (Basel, Switzerland) · 2024Article
- Cutting-edge Bioinformatics strategies for synthesizing Cyclotriazadisulfonamide (CADA) analogs in next-Generation HIV therapies.Scientific reports · 2024Article
- Review
- Application of magnetic deep eutectic solvents as an efficient catalyst in the synthesis of new 1,2,3-triazole-nicotinonitrile hybridsRSC advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug-resistant (MDR) pathogens have created a fatal problem for human health and antimicrobial treatment. Among the currently available antibiotics, many are inactive against MDR pathogens. In this context, heterocyclic compounds/drugs play a vital role. Thus, it is very much essential to explore new research to combat the issue. Of the available nitrogen-bearing heterocyclic compounds/drugs, pyridine derivatives are of special interest due to their solubility. Encouragingly, some of the newly synthesized pyridine compounds/drugs are found to inhibit multidrug-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.